NBIX Neurocrine Biosciences Inc

Neurocrine Biosciences Inc engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States.

$83.17  -1.57 (-1.85%)
As of 11/30/2021 15:59:58 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/26/2001
Outstanding shares:  94,866,693
Average volume:  863,393
Market cap:   $8,251,504,957
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    64125C109
ISIN:        US64125C1099
Sedol:      2623911
Valuation   (See tab for details)
PE ratio:   18.07
PB ratio:   5.97
PS ratio:   7.72
Return on equity:   33.05%
Net income %:   41.59%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy